Bevatres 10 mg/ 160 mg/ 25 mg Filmdragerad tablett

Երկիր: Շվեդիա

Լեզու: շվեդերեն

Աղբյուրը: Läkemedelsverket (Medical Products Agency)

Գնել հիմա

Ակտիվ բաղադրիչ:

amlodipinbesilat; hydroklortiazid; valsartan

Հասանելի է:

Teva B.V.

ATC կոդը:

C09DX01

INN (Միջազգային անվանումը):

amlodipinbesilat; hydrochlorothiazide; valsartan

Դոզան:

10 mg/ 160 mg/ 25 mg

Դեղագործական ձեւ:

Filmdragerad tablett

Կազմը:

hydroklortiazid 25 mg Aktiv substans; amlodipinbesilat 13,86 mg Aktiv substans; valsartan 160 mg Aktiv substans; laktosmonohydrat Hjälpämne

Ռեկվիզորի տեսակը:

Receptbelagt

Ապրանքի ամփոփագիր:

Förpacknings: Blister, 14 tabletter; Blister, 28 tabletter; Blister, 30 tabletter; Blister, 56 tabletter; Blister, 90 tabletter; Blister, 98 tabletter; Burk, 100 tabletter

Լիազորման կարգավիճակը:

Avregistrerad

Հաստատման ամսաթիվը:

2020-04-15

Ապրանքի հատկությունները

                                1
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Bevatres10 mg/160 mg/12.5 mg film-coated tablets
Bevatres5 mg/160 mg/25 mg film-coated tablets
Bevatres 10 mg/160 mg/25 mg film-coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
[Product name] 10 mg/160 mg/12.5 mg film-coated tablets
Each film-coated tablet contains amlodipine besilate equivalent to 10
mg amlodipine, 160 mg of
valsartan, and 12.5 mg of hydrochlorothiazide.
[Product name] 5 mg/160 mg/25 mg film-coated tablets
Each film-coated tablet containsamlodipine besilate equivalent to 5 mg
amlodipine, 160 mg of
valsartan, and 25 mg of hydrochlorothiazide.
[Product name] 10 mg/160 mg/25 mg film-coated tablets
Each film-coated tablet containsamlodipine besilate equivalent to 10
mg amlodipine, 160 mg of
valsartan, and 25 mg of hydrochlorothiazide.
Excipient(s) with known effect
[Product name] 10 mg/160 mg/12.5 mg film-coated tablets
Each tablet contains 5 mg of lactose.
[Product name] 5 mg/160 mg/25 mg film-coated tablets
Each tablet contains 5 mg of lactose.
[Product name] 10 mg/160 mg/25 mg film-coated tablets
Each tablet contains 5 mg of lactose.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film-coated tablet (tablet)
[Product name] 10 mg/160 mg/12.5 mg film-coated tablets
Oval, light yellow, 14.5 mm x 7.5 mm film-coated tablets with bevelled
edges, with debossing VIL on
one side of the tablet.
[Product name] 5 mg/160 mg/25 mg film-coated tablets
Oval, yellow, 14.5 mm x 7.5 mm film-coated tablets with bevelled
edges, with debossing VIH on one
side of the tablet
[Product name] 10 mg/160 mg/25 mg film-coated tablets
Oval, dark yellow, 14.5 mm x 7.5 mm film-coated tablets with bevelled
edges, with debossing VIT on
one side of the tablet.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
3
Treatment of essential hypertension as substitution therapy in adult
patients whose blood pressure is
adequately controlled on the combination of amlodipine, valsartan and
hydrochlorothiazide (HCT),
taken either as th
                                
                                Կարդացեք ամբողջական փաստաթուղթը
                                
                            

Փաստաթղթեր այլ լեզուներով